Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer

Arianna Bellazzo1,2, Giulio Di Minin3, Licio Collavin1,2

  • 1Laboratorio Nazionale CIB, AREA Science Park, Trieste 34149, Italy.

Insights

The tumor suppressor DAB2IP (Disabled homolog 2 interacting protein) is crucial for regulating cancer cell communication. Reactivating DAB2IP may offer a strategy to inhibit multiple cancer-promoting pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Aberrant cell communication is a hallmark of cancer, necessitating a deeper understanding of tumor microenvironment interactions.
  • DAB2IP (Disabled homolog 2 interacting protein), also known as AIP1 (ASK1 interacting protein), is a tumor suppressor involved in modulating inflammatory and growth factor signaling pathways.
  • DAB2IP functions as a Ras-GAP, negatively regulating Ras-dependent mitogenic signals, and also acts as a signaling adaptor for oncogenic pathways like TNFα/NF-κB, WNT/β-catenin, PI3K/AKT, and androgen receptors.

Purpose of the Study:

  • To review the mechanisms and consequences of DAB2IP inactivation in cancer.
  • To support and improve research aimed at counteracting DAB2IP inactivation mechanisms.
  • To propose DAB2IP reactivation as a potential therapeutic strategy for various cancers.

Main Methods:

  • Literature review of DAB2IP's role in cancer signaling.
  • Analysis of DAB2IP inactivation mechanisms, including methylation and post-transcriptional regulation.
  • Evaluation of DAB2IP's impact on multiple oncogenic pathways.

Main Results:

  • DAB2IP inactivation provides a selective advantage to tumors with various driver mutations.
  • DAB2IP expression is frequently impaired by methylation in cancer.
  • Tumor cells utilize post-transcriptional mechanisms to disable DAB2IP.

Conclusions:

  • DAB2IP plays a critical role in controlling key oncogenic signaling pathways.
  • Inactivation of DAB2IP contributes to tumor progression.
  • Reactivation of DAB2IP could simultaneously inhibit multiple oncogenic pathways, potentially limiting the progression of diverse tumors.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K